HSBC’s former head of currency trading has won a last-ditch battle to block his extradition to the US, reported Bloomberg. In the US he faces 11 charges of foreign exchange rigging which each carry a maximum 30-year prison sentence.
Stuart Scott on Tuesday, July 31, won an appeal in the UK high court against his extradition. The charges in the US relate to an alleged “front running” scheme in which he and his former boss have been accused of making more than US$8 million profit on currency deals arranged for the oil and gas exploration company Cairn Energy.
The Court of Appeal ruled that Scott should not be extradited because “most of the harm took place” in the UK and extradition was not in the interests of justice.
Scott had been charged alongside Mark Johnson, HSBC’s former head of global foreign exchange. Johnson, who is also British, was arrested at JFK airport in New York as he attempted to fly back to London in July 2016. Last year, he was found guilty of fraud and sentenced to two years in prison and fined US$300,000.
Lord Burnett, the lord chief justice, said a district judge who had allowed for Scott’s extradition had been mistaken and overturned the order.
After the ruling, Scott said he was very pleased, but declined to speak further as the US government has indicated it plans to appeal. He has denied all the charges.
Full Content: Bloomberg
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Top Antitrust Expert Joins Cravath from Paul Weiss
Jan 21, 2025 by
CPI
CMA Chief Removed as UK Government Targets Regulatory Overhaul
Jan 21, 2025 by
CPI
Court Denies Dismissal in Crab Price-Fixing Lawsuit
Jan 21, 2025 by
CPI
TikTok Stays Online for Now: Trump Floats US Ownership Deal
Jan 21, 2025 by
CPI
Hong Kong Watchdog Unveils Compliance Tool for Small Businesses
Jan 21, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Pharmacy Benefit Managers
Jan 20, 2025 by
CPI
Untangling the PBM Mess
Jan 20, 2025 by
Kent Bernard
Using Data, Not Anecdotes, to Analyze Criticisms of Pharmacy Benefit Managers
Jan 20, 2025 by
Dennis Carlton
Vertical Integration and PBMs: What, Me Worry?
Jan 20, 2025 by
Lawton Robert Burns & Bradley Fluegel
The Economics of Benefit Management in Prescription-Drug Markets
Jan 20, 2025 by
Casey B. Mulligan